glp-1 shortage news today november 2025 New project announcement: HHS‑OIG is taking a closer look at FDA's oversight of compounded GLP‑1 drugs. Although shortages ended in 2025, some facilities may still be producing these drugs at scale. Our GLP-1: Transforming weight loss and

The KPV peptide for inflammation article goes deeper into the anti-inflammatory mechanisms specifically

In spite of these copper-rich senile plaques found in AD (Bagheri et al., 2018), we see evidence of a more generalized brain-wide copper deficiency that is central to this disease (Xu et al., 2017), that has been postulated to be due to the copper binding ability of A leading to neuronal copper deficiency, a process that is exacerbated by the increased copper requirement in microglia (Bagheri et al., 2022)

and 83% of potential users said they would be more likely to take GLP-1s if they were available as a pill, according to PwC

Each serving (2 capsules) provides 500 mg of Setria L-glutathione plus 350 mg of a sunflower-based phospholipid blend